You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 14, 2025

CLINICAL TRIALS PROFILE FOR ACETIC ACID, GLACIAL


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for acetic acid, glacial

Trial IDTitleStatusSponsorPhaseStart DateSummary
NCT02488642 ↗ Medical Management of Late Intrauterine Death. Completed National Council of Science and Technology, Mexico Phase 4 2008-05-01 The purpose of this study is to assess the therapeutic efficacy and safety of isosorbide dinitrate-oxytocin in combination in the management of late intrauterine foetal death.
NCT02488642 ↗ Medical Management of Late Intrauterine Death. Completed National Institute of Perinatology Phase 4 2008-05-01 The purpose of this study is to assess the therapeutic efficacy and safety of isosorbide dinitrate-oxytocin in combination in the management of late intrauterine foetal death.
>Trial ID>Title>Status>Phase>Start Date>Summary
Showing 1 to 2 of 2 entries

Clinical Trial Conditions for acetic acid, glacial

Condition Name

110-0.100.10.20.30.40.50.60.70.80.911.1Cervical PregnancyMaternal Care for Late Fetal Death[disabled in preview]
Condition Name for acetic acid, glacial
Intervention Trials
Cervical Pregnancy 1
Maternal Care for Late Fetal Death 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

1110-0.100.10.20.30.40.50.60.70.80.911.1StillbirthFetal DeathDeath[disabled in preview]
Condition MeSH for acetic acid, glacial
Intervention Trials
Stillbirth 1
Fetal Death 1
Death 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for acetic acid, glacial

Clinical Trial Phase

100.0%0-0.100.10.20.30.40.50.60.70.80.911.1Phase 4[disabled in preview]
Clinical Trial Phase for acetic acid, glacial
Clinical Trial Phase Trials
Phase 4 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

100.0%0-0.100.10.20.30.40.50.60.70.80.911.1Completed[disabled in preview]
Clinical Trial Status for acetic acid, glacial
Clinical Trial Phase Trials
Completed 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for acetic acid, glacial

Sponsor Name

trials000001111111National Council of Science and Technology, MexicoNational Institute of Perinatology[disabled in preview]
Sponsor Name for acetic acid, glacial
Sponsor Trials
National Council of Science and Technology, Mexico 1
National Institute of Perinatology 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

100.0%0-0.200.20.40.60.811.21.41.61.822.2Other[disabled in preview]
Sponsor Type for acetic acid, glacial
Sponsor Trials
Other 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Glacial Acetic Acid: Clinical Trials, Market Analysis, and Projections

Introduction to Glacial Acetic Acid

Glacial acetic acid, a concentrated form of acetic acid, is a versatile chemical with a wide range of applications in various industries, including medical, chemical, and pharmaceutical sectors. This article will delve into the clinical trials, market analysis, and future projections of glacial acetic acid.

Clinical Trials and Medical Applications

Treatment of Otitis Externa

Glacial acetic acid has been studied for its efficacy in treating otitis externa, an infection of the outer ear. A prospective, single-blind randomized controlled trial compared the effectiveness of 2% glacial acetic acid alone versus a combination of 2% glacial acetic acid, 0.1% dexamethasone, and 3250 U/ml of neomycin sulphate. The results showed that the combination treatment was significantly more effective in resolving otitis externa, with 71% of patients showing resolution after 2 weeks and 86% after 4 weeks, compared to 38% with glacial acetic acid alone[4].

Impact on Pap Test Samples

In the context of gynecological diagnostics, glacial acetic acid is used to treat Pap test samples to prevent unsatisfactory results due to blood. However, it has been observed that this treatment can adversely affect the morphologic appearance of endocervical glandular cells, potentially leading to increased false-positive diagnoses of atypical endocervical cells (AECs)[1].

Market Analysis

Market Size and Growth

The global glacial acetic acid market is experiencing significant growth. As of 2021, the market was valued at USD 7.29 billion and is projected to reach USD 11.62 billion by 2029, with a CAGR of 6.00% during the forecast period[3].

Another report indicates that the global glacial acetic acid market size is expected to reach USD 8801.6 million in 2024 and grow at a CAGR of 6.5% to reach USD 16521.8 million by 2034[5].

Regional Market Dynamics

The Asia Pacific region is the fastest-growing and largest market for glacial acetic acid, driven by the continuous expansion of the chemical sector in this region. The market concentration is low, indicating a competitive landscape with multiple players[2][5].

Applications and End-Use Industries

Glacial acetic acid is used in various applications, including:

  • Food Additive: As a preservative and acidity regulator.
  • Solvent: In photographic films, preparation of dyes and inks.
  • Chemical Manufacturing: To produce adhesives, sealants, and other chemicals.
  • Pharmaceuticals: As an intermediate in drug production and as a pH regulator in formulations.
  • Textiles and Packaging: In the production of purified terephthalic acid (PTA) and polyethylene terephthalate (PET)[3][5].

Market Drivers and Opportunities

The growth of the glacial acetic acid market is driven by several factors:

  • Numerous Applications: Its use as an organic solvent, coating solution, and in various chemical and pharmaceutical processes.
  • High Usage in Chemical Industries: Extensive use in producing adhesives, sealants, and other chemicals.
  • Rising Applications and Advancements: Increasing use in the production of acetic anhydride, vinyl acetate monomer, and other intermediates[3].

Challenges and Restraints

Despite the growth, the market faces some challenges:

  • Unfavorable Market Conditions: Disruptions during the COVID-19 pandemic affected demand and supply chains.
  • Corrosive Nature: The corrosive properties of glacial acetic acid can create handling and storage challenges.
  • Fluctuations in Raw Material Prices: Volatility in raw material costs can impact production costs and profitability[3][5].

Future Projections

Sustainable and Bio-Based Production

There is a growing trend towards sustainable and bio-based production of glacial acetic acid. Manufacturers are investing in research and development to optimize production processes, reduce costs, and make domestic production more competitive. The use of novel and environmentally friendly feedstocks is expected to reduce the environmental footprint of glacial acetic acid production[5].

Increasing Demand in Key Sectors

The demand for glacial acetic acid is expected to increase in sectors such as electronics and pharmaceuticals, particularly for high-purity grades. The expansion of the chemical sector, especially in Asia Pacific, will continue to drive the market. Additionally, the growing awareness of environmental issues is influencing consumer preferences, making sustainability a key factor in market growth[5].

Regulatory Environment

Governments are implementing stringent environmental laws and offering incentives for bio-based acetic acid production. This regulatory environment is likely to further boost the market for glacial acetic acid as companies focus on sustainable practices[5].

Key Takeaways

  • Clinical Trials: Glacial acetic acid shows promise in treating otitis externa but may affect Pap test sample diagnostics.
  • Market Growth: The global market is expected to grow significantly, driven by its versatile applications and expanding chemical sector.
  • Regional Dynamics: Asia Pacific is the largest and fastest-growing market.
  • Sustainability: There is a growing trend towards sustainable and bio-based production.
  • Regulatory Environment: Stringent environmental laws and incentives for bio-based production are shaping the market.

FAQs

What are the primary medical applications of glacial acetic acid?

Glacial acetic acid is used in treating otitis externa and as a treatment for Pap test samples to prevent unsatisfactory results due to blood.

How is the global glacial acetic acid market expected to grow?

The global glacial acetic acid market is expected to grow at a CAGR of 6.00% to 6.5% over the forecast period, reaching values of USD 11.62 billion by 2029 and USD 16521.8 million by 2034.

What are the main drivers of the glacial acetic acid market?

The market is driven by its numerous applications, high usage in chemical industries, and rising applications and advancements in various sectors.

What challenges does the glacial acetic acid market face?

The market faces challenges such as unfavorable market conditions, the corrosive nature of glacial acetic acid, and fluctuations in raw material prices.

How is sustainability impacting the glacial acetic acid market?

There is a growing trend towards sustainable and bio-based production, driven by consumer awareness and stringent environmental regulations.

Sources

  1. Glacial Acetic Acid Treatment and Atypical Endocervical Glandular Cells - American Journal of Clinical Pathology[1]
  2. Glacial Acetic Acid Market - Growth Trends & Major Manufacturers - Mordor Intelligence[2]
  3. Global Glacial Acetic Acid Market – Industry Trends and Forecast to 2029 - Data Bridge Market Research[3]
  4. Prospective randomised single-blind controlled trial of glacial acetic acid - PubMed[4]
  5. Glacial Acetic Acid Market Size, Growth & Trends by 2034 - Future Market Insights[5]

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.